Free tool
Oncology stocks
We cover 3 companies grouped under the Oncology theme. The median market value in the group is $32.82M. Across the group, the median move over the past trading day is +1.32%. Price change over the past year runs from −25.1% to +57.8% across the middle 80 percent of the group, with a median of −22.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% | Oct 30, 2026 |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% | Nov 9, 2026 |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% | Nov 11, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.